Opposing roles of prion protein in oxidative stress- and ER stress-induced apoptotic signaling

Free Radical Biology and Medicine

Volumn 45, Issue 11, 2008, Pages 1530-1541

  Anantharam, Vellareddy ^a   Kanthasamy, Arthi ^a   Choi, Christopher J ^a   Martin, Dustin P ^a   Latchoumycandane, Calivarathan ^a   Richt, Jüergen A ^b   Kanthasamy, Anumantha G ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b NATIONAL ANIMAL DISEASE CENTER   (United States)

Author keywords

Caspases; Free radicals; Neurodegeneration; Prion diseases; Protein kinase C; Protein misfolding; Transgenic

Indexed keywords

BREFELDIN A; CASPASE 12; CASPASE 3; CASPASE 3 INHIBITOR; CASPASE 8; CASPASE 8 INHIBITOR; CASPASE 9; CASPASE 9 INHIBITOR; HYDROGEN PEROXIDE; MANGANESE DERIVATIVE; PRION PROTEIN; PROTEIN KINASE C DELTA; PROTEIN KINASE C INHIBITOR; TUNICAMYCIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA FRAGMENTATION; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; MOUSE; NERVE CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BREFELDIN A; CASPASES; CELL LINE; DNA FRAGMENTATION; ENDOPLASMIC RETICULUM; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MICE; MICE, KNOCKOUT; MUTANT PROTEINS; NEURONS; OXIDATIVE STRESS; PROTEIN KINASE C-DELTA; PRPC PROTEINS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TUNICAMYCIN;

EID: 56049121173     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.08.028     Document Type: Article

References (72)

1. McKintosh E., Tabrizi S.J., and Collinge J. Prion diseases. J. Neurovirol. 9 (2003) 183-193
2. Prusiner S.B., Scott M.R., DeArmond S.J., and Cohen F.E. Prion protein biology. Cell 93 (1998) 337-348
3. Priola S.A., Chesebro B., and Caughey B. A view from the top-prion diseases from 10,000 feet. Science 300 (2003) 917-919
4. Brown P., and Cervenakova L. A prion lexicon (out of control). Lancet 365 (2005) 122
5. Chiesa R., and Harris D.A. Prion diseases: what is the neurotoxic molecule. Neurobiol. Dis. 8 (2001) 743-763
6. Aguzzi A., and Polymenidou M. Mammalian prion biology: one century of evolving concepts. Cell 116 (2004) 313-327
7. Weissmann C. The state of the prion. Nat. Rev. Microbiol. 2 (2004) 861-871
8. Castilla J., Saa P., Hetz C., and Soto C. In vitro generation of infectious scrapie prions. Cell 121 (2005) 195-206
9. Legname G., Baskakov I.V., Nguyen H.O., Riesner D., Cohen F.E., DeArmond S.J., and Prusiner S.B. Synthetic mammalian prions. Science 305 (2004) 673-676
10. Forman M.S., Trojanowski J.Q., and Lee V.M. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat. Med. 10 (2004) 1055-1063
11. Dawson T.M., and Dawson V.L. Molecular pathways of neurodegeneration in Parkinson's disease. Science 302 (2003) 819-822
12. Reed J.C. Apoptosis mechanisms: implications for cancer drug discovery. Oncology 18 (2004) 11-20
13. Cain K., Bratton S.B., and Cohen G.M. The Apaf-1 apoptosome: a large caspase-activating complex. Biochimie 84 (2002) 203-214
14. Gorman A.M., Ceccatelli S., and Orrenius S. Role of mitochondria in neuronal apoptosis. Dev. Neurosci. 22 (2000) 348-358
15. Rao R.V., Ellerby H.M., and Bredesen D.E. Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ. 11 (2004) 372-380
16. Szegezdi E., Fitzgerald U., and Samali A. Caspase-12 and ER-stress-mediated apoptosis: the story so far. Ann. N. Y. Acad. Sci. 1010 (2003) 186-194
17. Momoi T. Caspases involved in ER stress-mediated cell death. J. Chem. Neuroanat. 28 (2004) 101-105
18. Jimbo A., Fujita E., Kouroku Y., Ohnishi J., Inohara N., Kuida K., Sakamaki K., Yonehara S., and Momoi T. ER stress induces caspase-8 activation, stimulating cytochrome c release and caspase-9 activation. Exp. Cell Res. 283 (2003) 156-166
19. Kim J.I., Choi S.I., Kim N.H., Jin J.K., Choi E.K., Carp R.I., and Kim Y.S. Oxidative stress and neurodegeneration in prion diseases. Ann. N. Y. Acad. Sci. 928 (2001) 182-186
20. Milhavet O., and Lehmann S. Oxidative stress and the prion protein in transmissible spongiform encephalopathies. Brain Res. Brain Res. Rev. 38 (2002) 328-339
21. Wong B.S., Pan T., Liu T., Li R., Petersen R.B., Jones I.M., Gambetti P., Brown D.R., and Sy M.S. Prion disease: a loss of antioxidant function?. Biochem. Biophys. Res. Commun. 275 (2000) 249-252
22. Senator A., Rachidi W., Lehmann S., Favier A., and Benboubetra M. Prion protein protects against DNA damage induced by paraquat in cultured cells. Free Radic. Biol. Med. 37 (2004) 1224-1230
23. Brown D.R., Nicholas R.S., and Canevari L. Lack of prion protein expression results in a neuronal phenotype sensitive to stress. J. Neurosci. Res. 67 (2002) 211-224
24. Kim B.H., Lee H.G., Choi J.K., Kim J.I., Choi E.K., Carp R.I., and Kim Y.S. The cellular prion protein (PrPC) prevents apoptotic neuronal cell death and mitochondrial dysfunction induced by serum deprivation. Brain Res. Mol. Brain Res. 124 (2004) 40-50
25. White A.R., Collins S.J., Maher F., Jobling M.F., Stewart L.R., Thyer J.M., Beyreuther K., Masters C.L., and Cappai R. Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity. Am. J. Pathol. 155 (1999) 1723-1730
26. Roucou X., Gains M., and LeBlanc A.C. Neuroprotective functions of prion protein. J. Neurosci. Res. 75 (2004) 153-161
27. Hetz C., Maundrell K., and Soto C. Is loss of function of the prion protein the cause of prion disorders?. Trends Mol. Med. 9 (2003) 237-243
28. Thellung S., Villa V., Corsaro A., Arena S., Millo E., Damonte G., Benatti U., Tagliavini F., Florio T., and Schettini G. p38 MAP kinase mediates the cell death induced by PrP106-126 in the SH-SY5Y neuroblastoma cells. Neurobiol. Dis. 9 (2002) 69-81
29. O'Donovan C.N., Tobin D., and Cotter T.G. Prion protein fragment PrP-(106-126) induces apoptosis via mitochondrial disruption in human neuronal SH-SY5Y cells. J. Biol. Chem. 276 (2001) 43516-43523
30. Marella M., Gaggioli C., Batoz M., Deckert M., Tartare-Deckert S., and Chabry J. Pathological prion protein exposure switches on neuronal mitogen-activated protein kinase pathway resulting in microglia recruitment. J. Biol. Chem. 280 (2005) 1529-1534
31. Cronier S., Laude H., and Peyrin J.M. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 12271-12276
32. Fioriti L., Quaglio E., Massignan T., Colombo L., Stewart R.S., Salmona M., Harris D.A., Forloni G., and Chiesa R. The neurotoxicity of prion protein (PrP) peptide 106-126 is independent of the expression level of PrP and is not mediated by abnormal PrP species. Mol. Cell. Neurosci. 28 (2005) 165-176
33. Chiesa R., Piccardo P., Dossena S., Nowoslawski L., Roth K.A., Ghetti B., and Harris D.A. Bax deletion prevents neuronal loss but not neurological symptoms in a transgenic model of inherited prion disease. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 238-243
34. Hetz C., Russelakis-Carneiro M., Maundrell K., Castilla J., and Soto C. Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO J. 22 (2003) 5435-5445
35. Brandner S., Isenmann S., Raeber A., Fischer M., Sailer A., Kobayashi Y., Marino S., Weissmann C., and Aguzzi A. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379 (1996) 339-343
36. Mallucci G., Dickinson A., Linehan J., Klohn P.C., Brandner S., and Collinge J. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302 (2003) 871-874
37. Roucou X., and LeBlanc A.C. Cellular prion protein neuroprotective function: implications in prion diseases. J. Mol. Med. 83 (2005) 3-11
38. Ma J., and Lindquist S. Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol. Science 298 (2002) 1785-1788
39. Ma J., Wollmann R., and Lindquist S. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298 (2002) 1781-1785
40. Solforosi L., Criado J.R., McGavern D.B., Wirz S., Sanchez-Alavez M., Sugama S., DeGiorgio L.A., Volpe B.T., Wiseman E., Abalos G., Masliah E., Gilden D., Oldstone M.B., Conti B., and Williamson R.A. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 303 (2004) 1514-1516
41. Anantharam V., Kitazawa M., Latchoumycandane C., Kanthasamy A., and Kanthasamy A.G. Blockade of PKC{delta} proteolytic activation by loss of function mutants rescues mesencephalic dopaminergic neurons from methylcyclopentadienyl manganese tricarbonyl (MMT)-induced apoptotic cell death. Ann. N. Y. Acad. Sci. 1035 (2004) 271-289
42. Anantharam V., Kitazawa M., Wagner J., Kaul S., and Kanthasamy A.G. Caspase-3-dependent proteolytic cleavage of protein kinase Cdelta is essential for oxidative stress-mediated dopaminergic cell death after exposure to methylcyclopentadienyl manganese tricarbonyl. J. Neurosci. 22 (2002) 1738-1751
43. Chen L., and Gao X. Neuronal apoptosis induced by endoplasmic reticulum stress. Neurochem. Res. 27 (2002) 891-898
44. Brodie C., and Blumberg P.M. Regulation of cell apoptosis by protein kinase C delta. Apoptosis 8 (2003) 19-27
45. Kanthasamy A.G., Kitazawa M., Kanthasamy A., and Anantharam V. Role of proteolytic activation of protein kinase Cdelta in oxidative stress-induced apoptosis. Antioxid. Redox Signal. 5 (2003) 609-620
46. Kikkawa U., Matsuzaki H., and Yamamoto T. Protein kinase C delta (PKC delta): activation mechanisms and functions. J. Biochem. (Tokyo) 132 (2002) 831-839
47. Chun H.S., Lee H., and Son J.H. Manganese induces endoplasmic reticulum (ER) stress and activates multiple caspases in nigral dopaminergic neuronal cells, SN4741. Neurosci. Lett. 316 (2001) 5-8
48. Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B.A., and Yuan J. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403 (2000) 98-103
49. Mehmet H. Caspases find a new place to hide. Nature 403 (2000) 29-30
50. Kim S.J., Zhang Z., Hitomi E., Lee Y.C., and Mukherjee A.B. Endoplasmic reticulum stress-induced caspase-4 activation mediates apoptosis and neurodegeneration in INCL. Hum. Mol. Genet. 15 (2006) 1826-1834
51. Obeng E.A., and Boise L.H. Caspase-12 and caspase-4 are not required for caspase-dependent endoplasmic reticulum stress-induced apoptosis. J. Biol. Chem. 280 (2005) 29578-29587
52. Dawson M., Warner R., Nolan A., McKeown B., and Thomson J. 'Complex' PrP genotypes identified by the National Scrapie Plan. Vet. Rec. 152 (2003) 754-755
53. Caramelli M., Ru G., Acutis P., and Forloni G. Prion diseases: current understanding of epidemiology and pathogenesis, and therapeutic advances. CNS Drugs 20 (2006) 15-28
54. Campana V., Sarnataro D., and Zurzolo C. The highways and byways of prion protein trafficking. Trends Cell Biol. 15 (2005) 102-111
55. Choi C.J., Kanthasamy A., Anantharam V., and Kanthasamy A.G. Interaction of metals with prion protein: possible role of divalent cations in the pathogenesis of prion diseases. Neurotoxicology 27 (2006) 777-787
56. Aguzzi A. Prion diseases of humans and farm animals: epidemiology, genetics, and pathogenesis. J. Neurochem. 97 (2006) 1726-1739
57. Harris D.A., and True H.L. New insights into prion structure and toxicity. Neuron 50 (2006) 353-357
58. Brown D.R. Neurodegeneration and oxidative stress: prion disease results from loss of antioxidant defence. Fol. Neuropathol. 43 (2005) 229-243
59. Hetz C.A., and Soto C. Stressing out the ER: a role of the unfolded protein response in prion-related disorders. Curr. Mol. Med. 6 (2006) 37-43
60. Taylor D.R., and Hooper N.M. The prion protein and lipid rafts. Mol. Membr. Biol. 23 (2006) 89-99
61. Orsi A., Fioriti L., Chiesa R., and Sitia R. Conditions of endoplasmic reticulum stress favor the accumulation of cytosolic prion protein. J. Biol. Chem. 281 (2006) 30431-30438
62. Kiachopoulos S., Heske J., Tatzelt J., and Winklhofer K.F. Misfolding of the prion protein at the plasma membrane induces endocytosis, intracellular retention and degradation. Traffic 5 (2004) 426-436
63. Yedidia Y., Horonchik L., Tzaban S., Yanai A., and Taraboulos A. Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein. EMBO J. 20 (2001) 5383-5391
64. Zhang C.C., Steele A.D., Lindquist S., and Lodish H.F. Prion protein is expressed on long-term repopulating hematopoietic stem cells and is important for their self-renewal. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 2184-2189
65. Steele A.D., Emsley J.G., Ozdinler P.H., Lindquist S., and Macklis J.D. Prion protein (PrPc) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 3416-3421
66. Zanusso G., Petersen R.B., Jin T., Jing Y., Kanoush R., Ferrari S., Gambetti P., and Singh N. Proteasomal degradation and N-terminal protease resistance of the codon 145 mutant prion protein. J. Biol. Chem. 274 (1999) 23396-23404
67. Hachiya N.S., Watanabe K., Kawabata M.Y., Jozuka A., Kozuka Y., Sakasegawa Y., and Kaneko K. Prion protein with Y145STOP mutation induces mitochondria-mediated apoptosis and PrP-containing deposits in vitro. Biochem. Biophys. Res. Commun. 327 (2005) 894-899
68. Fioriti L., Dossena S., Stewart L.R., Stewart R.S., Harris D.A., Forloni G., and Chiesa R. Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations. J. Biol. Chem. 280 (2005) 11320-11328
69. Drisaldi B., Stewart R.S., Adles C., Stewart L.R., Quaglio E., Biasini E., Fioriti L., Chiesa R., and Harris D.A. Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation. J. Biol. Chem. 278 (2003) 21732-21743
70. Gu Y., Hinnerwisch J., Fredricks R., Kalepu S., Mishra R.S., and Singh N. Identification of cryptic nuclear localization signals in the prion protein. Neurobiol. Dis. 12 (2003) 133-149
71. Priola S.A., Chabry J., and Chan K. Efficient conversion of normal prion protein (PrP) by abnormal hamster PrP is determined by homology at amino acid residue 155. J. Virol. 75 (2001) 4673-4680
72. Takemura K., Wang P., Vorberg I., Surewicz W., Priola S.A., Kanthasamy A., Pottathil R., Chen S.G., and Sreevatsan S. DNA aptamers that bind to PrP(C) and not PrP(Sc) show sequence and structure specificity. Exp. Biol. Med. 231 2 (2006) 204-214